InvestorsHub Logo
Followers 78
Posts 11422
Boards Moderated 0
Alias Born 04/03/2014

Re: BIOChecker4 post# 360697

Thursday, 05/19/2022 1:40:09 PM

Thursday, May 19, 2022 1:40:09 PM

Post# of 462570
I completely agree with you - like most small biotech CEOs, M has enriched himself by giving himself dis-proportionate overall compensation for under-delivering year after year.

I am still here for the AD P2/3 results - that is literally a make or break event.

If the results are not so good or bad - we’ll, that is end of AVXL. The Rett and other trials will not have any effect and it will be difficult for the co to survive.

So all the did-proportionate compensation will be forgotten if the results are good. If results are not good, SP will tank and all the big numbers of stock options will be worthless.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent AVXL News